Mimedx (MDXG) Superinvestor holders
13 of the superinvestors we track hold Mimedx (MDXG) in their latest 13F filings, $54M in total.
Summary
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $18M, 1.1% of the portfolio.
In their latest quarter: 6 added, 7 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Wilmot Harkey Nantahala Capital Management |
Added | 4,767,552 | $18M | 1.1% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 2,467,005 | $9M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 2,444,230 | $9M | 0.0% | Q2 2026 |
| J. Carlo Cannell Cannell Capital |
Added | 1,870,436 | $7M | 5.0% | Q2 2026 |
| Arrowstreet Capital | Added | 1,266,571 | $5M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 421,367 | $2M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 246,625 | $949,506 | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 204,856 | $788,695 | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 123,557 | $475,694 | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 53,414 | $205,644 | 0.0% | Q2 2026 |
| Chuck Royce Royce Investment Partners |
Added | 20,072 | $93,536 | 0.0% | Q3 2026 |
| Alan Howard Brevan Howard |
Trimmed | 10,819 | $41,653 | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Trimmed | 5,638 | $26,000 | 0.0% | Q3 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 14 |
| Q1 2026 | 17 |
| Q4 2025 | 15 |
| Q3 2025 | 13 |
| Q2 2025 | 10 |
| Q1 2025 | 10 |
| Q4 2024 | 10 |
| Q3 2024 | 9 |
Questions about Mimedx
Which superinvestors own Mimedx?
13 of the superinvestors we track hold Mimedx (MDXG) in their latest 13F filings, $54M in total. Wilmot Harkey, Cliff Asness, Jim Simons, J. Carlo Cannell, Arrowstreet Capital, David Shaw.
Who is the largest superinvestor holder of MDXG?
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $18M, 1.1% of the portfolio.
From Mimedx's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.